News
Ervebo is a recombinant, replication-competent Ebola vaccine, originally developed by NewLink Genetics and licensed to Merck in 2014, that has been given to hundreds of thousands of people in the ...
As Ebola swept through Sierra Leone in 2014, there were no approved vaccines against the disease. In 2019, the WHO prequalified the Ervebo vaccine and Gavi formally approved the establishment of a ...
A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.
This is the second Ebola vaccine approved by the European Commission: in November it granted a marketing authorisation to MSD’s vaccine known as Ervebo. This vaccine has been shown to produce ...
Most Americans have encountered false claims about the measles vaccine, and many aren’t sure what the truth is, according to a KFF poll released Wednesday. Misconceptions about measles ...
HHS Secretary Robert F. Kennedy Jr. is weighing pulling the Covid-19 vaccine from the government’s list of recommended immunizations for children, two people familiar with the discussions told ...
DTaP and Tdap are combination vaccines that protect against tetanus, diphtheria and whooping cough. DTaP is given to infants and young children, whereas Tdap is administered to anyone above the ...
He added that while this is an early-stage study, the same kind of vaccine is being developed for Ebola, m-pox, shingles, Alzheimer’s, and Parkinson’s. “Agricultural operations have a major ...
The African country of Sierra Leone is set to begin its rollout of the Ebola vaccine, 10 years after a historic outbreak of the virus. The government's vaccine campaign, developed in collaboration ...
Any hopes that Mr. Kennedy’s noxious views on vaccines would moderate with responsibility were always wishful thinking. It may be impossible to change his course, but that doesn’t mean those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results